Volume : 10, Issue : 07, July – 2023

Title:

15.FORMULATION DEVELOPMENT AND CHARACTERIZATION OF ISONIAZID NANOPARTICLES

Authors :

Nurukurthi Sushmitha Shainey*, Mrs. Raj Khiani, Dr T.K.V. Kesav Rao

Abstract :

Nanoparticles represent a promising drug delivery system of controlled and targeted drug release. They are specially designed to release the drug in the vicinity of target tissue. The aim of this study was to prepare and evaluate nanoparticles containing Isoniazid in different drug to polymer ratio by solvent evaporation technique. Prepared Nanoparticle was evaluated for its Particle Size, scanning electron microscopy, Percentage practical yield, Drug Entrapment Efficiency, and in-vitro drug release studies. FT-IR studies indicated that there was no chemical interaction between drug and polymer and stability of drug.
The optimized Nanoparticles were found with particle size of 95.41 nm, percentage practical yield was 96.72 %. Entrapment efficiency (% EE) of 93.20 %, scanning electron microscopy irregular shape. The in-vitro release profile was found to be 98.19% sustained up to 12 h.
The developed formulation overcome and alleviates the drawbacks and limitations of Isoniazid sustained release formulations and could possibility be advantageous in terms of increased bioavailability of Isoniazid.
Keywords : Nanoparticles, Isoniazid and solvent evaporation technique

Cite This Article:

Please cite this article in press Nurukurthi Sushmitha Shainey et al, Formulation Development And Characterization Of Isoniazid Nanoparticles., Indo Am. J. P. Sci, 2023; 10 (07).

Number of Downloads : 10

References:

1. Remington: The Science and Practice of Pharmacy, 20th Edition, Vol. 1 Edited by Alfonso R Gennaro Published by Lippincot Williams and Wilkins, Philadelphia, 2000; Page No. 903.
2. Controlled Drug Delivery Fundamentals and Applications, 2nd Edition edited by Robonson JR, Lee VHL, New York: Dekker, 1987; Page No. 3.
3. Controlled and Novel Drug Delivery”, 1st Edition, Edited by Jain NK, Published by CBS Publishers & Distributors, New Delhi, 1997; Page No. 1.
4. The Theory & Practice of Industrial Pharmacy, 3rd Edition Edited by Leon Lachman, Herbert A. Liberman, Joseph L.Kanig Published by, Varghese Publishing House, Bombay, 1991; Page No. 430-439.
5. Targeted and Controlled Drug Delivery Novel Carrier Systems. 1st Edition, Edited by SP Vyas and Khar RK, CBS Publishers & Distributors, New Delhi, 2002; Page No. 39.
6. Subal C Basak, Novel Drug Delivery Systems. The Indian Pharmacist, April 2005: 7-10.
7. Pharmaceutical Biotechnology, 1st Edition Edited by Vyas SP and Dixit VK, Published by CBS Publishers & Distributors, New Delhi, Page No. 395; 1998.
8. Encyclopedia of Pharmaceutical Technology, 2nd Edition edited by Elias Fattal, Christine Vauhier. Published by, Marcel Dekker, Inc. New York, 2002; pg (1864).
9. L.S. Nair, C.T. Laurencin. Prog. Polym. Sci. 32 (2007) 762–798.
10. VJ Mohanraj and Y Chen, Nanoparticles – A Review, Tropical Journal of Pharmaceutical Research, June 2006; 5 (1): 561-573.
11. R. Singh, J.W. Lillard Jr. / Experimental and Molecular Pathology 86 (2009) 215–223.
12. Peltonen L, Aitta J, Hyvönen S, Karjalainen M, Hirvonen J. Improved Entrapment Efficiency of Hydrophilic Drug Substance During Nanoprecipitation of Poly(l)lactide Nanoparticles. AAPS Pharm Sci Tech. 2004; 5(1): article 16.
13. T. Musumeci, C.A. Ventura, I. Giannone, B. Ruozi, L. Montenegro, R. Pignatello and G. Puglisi. PLA/PLGA nanoparticles for sustained release of Docetaxel. International Journal of Pharmaceutics Volume 325, Issues 1-2, 15 November 2006, Pages 172-179.
14. Lim Liancy, Feng Si-Shen and Seow Pei Hsing. Nanoparticles of Biodegradable polymers Applied for clinical Administration of Anti cancer Drugs. www3.ntu.edu. UROP Report
15. L.Mu and S.S.Feng worked on A novel controlled release formulation for the anticancer drug Paclitaxel(taxol);PLGA nanoparticles containing Vit E TPGS. Journal of controlled Release 86(2003) 33-48.
16. N.Jawahar*, T.Eagappanath, Nagasamy Venkatesh, Jubie.S, Samanta M.K, worked on preparation and characterization of PLGA-Nanoparticles containing Anti-hypertensive agents. International Journal of PharmTech Research, Vol.1, No.2, April-June 2009,pp 390-393.
17. Raghavan Pillai, Shankari N Somayaji, Monica Rabinovich, Michael C Hudson and Kenneth E Gonsalves. worked on Naficillin loaded PLGA for treatment of osteomyelitis. Biomed. Mater. 3 034114 (7pp) doi: 10.1088/1748-6041/3/3/034114.
18. Avinash Budhiana, Steven J. Siegelb, , and Karen I. Wineya, c, worked on Production of haloperidol loaded PLGA nanoparticles for extended controlled drug release of Haloperidol. International Journal of Pharmaceutics Volume 336, Issue 2, 24 May 2007, Pages 367-375
19. Esmaeili F, Atyabi F., and Dinarvand R.l worked on Preparation and characterization of estradiol loaded PLGA nano particles using homogenization solvent diffusion method. DARU Vol. 16, No.4 2008 page no 196-202.
20. Swathi Sashmal Swati sashmal, Swarupananda Mukherjee, Subhabrata Ray, Ram Sharnagat Thakur, Lakshmi K.Ghosh and Bijan K.Gupta worked on design and optimization of NSAIDS loaded nanoparticles. Pak. J. Pharm. Sci., 2007, Vol.20(2), 157-162.
21. Petra Kocbek, Nataša Obermajer, Mateja Cegnar, Janko Kos and Julijana Kristlet al worked on Targeting cancer cell using PLGA nanoparticles surface modified with monoclonal antibody. Journal of Controlled Release Volume 120, Issues 1-2, 13 July 2007, Pages 18-26

</div8